Sissetulev kiriAvalik
Küsimused
Ravimiamet · 28. märts 2025
- Viit
- MSO-2/1636-1
- Registreeritud
- 28. märts 2025
- Dokumendi liik
- Sissetulev kiri
- Adressaat
- COMPLIFE ITALIA
- Saabumis/saatmisviis
- e-post
- Funktsioon
- MSO Meditsiiniseadmed
- Sari
- MSO-2 Eesti turule lastavate/kasutusele võetavate/levitatavate seadmete teavitused ning EC sertifikaadid
- Toimik
- MSO-2/2025
- Vastutaja
- Maarika Ojala (RA, Meditsiiniseadmete osakond)
Sisu (failidest)
Saatja: Kärolin Jenas </O=SOTSIAALMINISTEERIUM/OU=EXCHANGE ADMINISTRATIVE GROUP (FYDIBOHF23SPDLT)/CN=RECIPIENTS/CN=USER3064555E>
Saaja: RA MSO
Teema: FW: MEDICAL DEVICE NOTIFICATION
From: Annamaria Mastropietro <[email protected]>
Sent: neljapäev, 27. märts 2025 18:53
To: Ravimiamet <[email protected]>
Subject: MEDICAL DEVICE NOTIFICATION
Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada.
To whom it may concern
I wolud like a clarification about obbligations of medical device notification in Estonia.
Is the notification of class IIa and IIb medical devices of an european but not estonian manufacturer mandatory?
Best regards,
ANNAMARIA MASTROPIETRO
QA/RA Specialist
<https://www.complifegroup.com/>
COMPLIFE ITALIA
Via Guido Rossa, 1
20024 Garbagnate Milanese (MI) - Italy
T: +39 02 99025138
www.complifegroup.com <http://complifegroup.com/>
<https://www.in-cosmetics.com/global/en-gb/lp/register-now.html?utm_source=google&utm_medium=cpc&utm_campaign=bof_branded&gad_source=1&gclid=Cj0KCQjw1um-BhDtARIsABjU5x78oPhl3laQMGDvbSbFOjmn6qs9QluzU9xatu9zMp-M9tdYZbwhG8kaAi6jEALw_wcB>
Think before you print
DISCLAIMER
Le informazioni contenute in questo messaggio di posta elettronica sono riservate e confidenziali e ne è vietata la diffusione in qualunque modo eseguita. Qualora Lei non fosse la persona a cui il presente messaggio è destinato La invitiamo ad eliminarlo e a non leggerlo, dandocene gentilmente comunicazione al seguente indirizzo di posta elettronica: [email protected] <mailto:[email protected]>
The information contained in this e-mail and any attachments are confidential and may also be privileged. If you are not named recipient, please notify immediately at this e-mail address: [email protected] <mailto:[email protected]> and do not disclose the contents to another person, use it for any purpose, or store or copy the information in any medium.